This company has shut down. Chroma Medicine is no longer operating — its last tracked round was a Series B in 2023.
Explore the Startup GraveyardChroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.
Chroma Medicine has raised $135.0M in total funding. The most recent round was Series B. The last funding was announced in February 2023.
Chroma Medicine's investors include ARCH Venture Partners, Cormorant Asset Management, Janus Henderson Investors, DCVC Bio, Wellington Management.
Chroma Medicine is headquartered in Cambridge, United States.
Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.
Chroma Medicine is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Chroma Medicine — Funding & Investors." VCBacked, February 28, 2023, https://www.vcbacked.co/company/chroma-medicine. Accessed September 30, 2026.
VCBacked. (2023). Chroma Medicine — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/chroma-medicine
{{cite web |title=Chroma Medicine — Funding & Investors |url=https://www.vcbacked.co/company/chroma-medicine |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated